The MEVION S250-FIT Proton Therapy System (Photo: Business Wire)
News | Proton Therapy
Mevion Introduces New MEVION S250-FIT Proton Therapy System

October 24, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time October 24, 2022
Home
Randomized trial finds hypofractionated whole-breast radiation with concurrent boost comparable to six weeks of treatment for patients with higher-risk disease
News | Breast Imaging
Three-week Course of Radiation Safe and Effective for Patients with Early-stage Breast Cancer and Elevated Risk of Recurrence

October 24, 2022 — A three-week course of radiation therapy is as safe and effective as four to six weeks of treatment ...

Time October 24, 2022
Home
Machine-learning method identifies rapid drops in patients’ activity levels to signal need for additional care
News | Artificial Intelligence
AI Model Using Daily Step Counts Predicts Unplanned Hospitalizations During Cancer Therapy

October 24, 2022 — An artificial intelligence (AI) model developed by researchers can predict the likelihood that a ...

Time October 24, 2022
Home
Evidence from VA medical centers nationwide supports benefits of prostate cancer screening
News | Prostate Cancer
Lower Prostate Cancer Screening Rates Associated with Subsequent Increase in Advanced Cancers

October 24, 2022 — In the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings ...

Time October 24, 2022
Home
Randomized phase III trial indicates SBRT is an option for patients ineligible for other local therapies
News | Radiation Oncology
Adding Radiation to Systemic Therapy Extends Overall Survival for Patients with Advanced Liver Cancer

October 24, 2022 — Adding radiation therapy to systemic therapy for patients with advanced liver cancer can extend ...

Time October 24, 2022
Home
Phase II trial suggests radiation could ward off complications of bone lesions and extend overall survival for patients with advanced cancers
News | Radiation Therapy
Radiation Therapy for High-risk, Asymptomatic Bone Metastases May Prevent Pain and Prolong Life

October 23, 2022 — Treating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and ...

Time October 23, 2022
Home
Randomized, phase III clinical trial finds patients who are educated about technical aspects of care less likely to report high levels of anxiety
News | Radiation Therapy
Medical Physicist Consults with Patients can Help Reduce Anxiety and Increase Satisfaction with Radiation Care

October 23, 2022 — Meeting with a medical physicist who can explain how radiation therapy is planned and delivered ...

Time October 23, 2022
Home
Ultra-high dose-rate radiation treatment found safe and effective for pain relief in small trial of patients with metastatic cancer
News | Proton Therapy
FLASH Radiation Therapy Shows Promise in First-in-human Trial

October 23, 2022 — FLASH radiation treatment – which delivers therapeutic doses of radiation in a fraction of a second – ...

Time October 23, 2022
Home
Phase III study provides randomized evidence of equivalent outcomes and side effects with 5 vs. 8 weeks of radiation for high-risk disease
News | Prostate Cancer
Shortened Course of Radiation Therapy Safe and Effective for Men with High-risk Prostate Cancer

October 23, 2022 — A new randomized study confirms that men with high-risk prostate cancer can be treated with five ...

Time October 23, 2022
Home
Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology (ASTRO) annual meeting
News | Proton Therapy
Together with Siemens Healthineers, Varian Showcases Technologies and Services Spanning the Full Cancer Care Continuum at ASTRO 2022

October 21, 2022 — Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end ...

Time October 21, 2022
Home
Clinical outcome oral presentations on SMART Pancreas and MIRAGE prostate studies Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology (ASTRO) annual meeting
News | Radiation Therapy
MRIdian Clinical Studies and Initial MRIdian A3i Clinical Experience to be Highlighted at ASTRO 2022

October 21, 2022 — ViewRay, Inc. (NASDAQ: VRAY) today announced that the company's MRIdian MRI-Guided Radiation Therapy ...

Time October 21, 2022
Home
Longitudinal and transverse grayscale ultrasound images of thyroid nodule in 17-year-old patient with benign follicular adenoma, based on surgical excision alone. Overall impression for all three radiologists was benign (true negative). ACR TI-RADS recommendation for all three radiologists was FNA (false positive). Deep learning algorithm recommendation was FNA (false positive).
News
TI-RADS, Algorithm Guide Diagnoses of Pediatric Thyroid Nodules on Ultrasound

October 21, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), ACR ...

Time October 21, 2022
Home
Study highlights gender disparity in how frequently doctors and clinical trials assess the impact of treatment on sexual health
News | Clinical Case Studies
Sexual Side Effects of Cancer Treatment Often Unaddressed with Female Patients

October 21, 2022 — A new study finds that sexual side effects of cancer treatment are discussed far less frequently with ...

Time October 21, 2022
Home
18F-SMBT-1 PET studies showed that beta-amyloid+ Alzheimer’s disease (AD) patients, but most importantly, beta-amyloid+ controls (CN) have significantly higher regional 18F-SMBT-1 binding than beta-amyloid- CN, with 18F-SMBT-1 retention highly associated with beta-amyloid burden. These findings suggest that increased 18F-SMBT-1 binding is detectable at the preclinical stages of beta-amyloid accumulation.
News | PET Imaging
Novel PET Imaging Agent Detects Earliest Signs of Alzheimer's Disease

October 20, 2022 — A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B ...

Time October 20, 2022
Home
https://www.itnonline.com/content/photo-gallery-how-covid-19-appears-medical-imaging
News | Coronavirus (COVID-19)
Long COVID Implications: Increased Health Care Use After Infection With SARS-Cov-2

October 20, 2022 — A large study on the impact of long COVID found increased rates of health system use 2 months after ...

Time October 20, 2022
Home
A cohort study of more than one million people has found that most persons screened for lung cancer meet U.S. Preventative Services Task Force (USPSTF) criteria
News | Lung Imaging
Most Persons Screened for Lung Cancer Meet USPSTF Criteria, But Adherence to Follow-Up Screening Low

October 20, 2022 — A cohort study of more than one million people has found that most persons screened for lung cancer ...

Time October 20, 2022
Home
FDA 510(k) clearance for AI-enabled Philips MR for Calculating Attenuation (MRCAT) Head and Neck radiotherapy application expands range of MR-only workflows
News | Magnetic Resonance Imaging (MRI)
Philips Advances MR Radiotherapy Imaging and Simulation for Head and Neck Cancers

October 20, 2022 — Royal Philips, a global leader in health technology, announced two new advances in MR-only workflows ...

Time October 20, 2022
Home
100-Micron pixel pitch delivers extraordinary image quality
News | Digital Radiography (DR)
Carestream Launches Affordable High-Definition Detectors for Medical Imaging

October 19, 2022 — Carestream Health is expanding its family of DR Detectors with two new 100-micron pixel pitch ...

Time October 19, 2022
Home
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced the signing of a data-sharing agreement with Siemens Healthineers and the University Hospital of the Technical University of Munich (TUM) for anonymized 18F-rhPSMA-7.3 clinical data and images.
News | PET Imaging
Blue Earth Diagnostics Announces Data-sharing Agreement with Siemens Healthineers and the University Hospital of Technical University of Munich (TUM) for 18F-rhPSMA-7.3

October 19, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 19, 2022
Home
Left: Recombined image of the CEM exam showing iodine uptake. Right: Standard digital mammogram.
News | Breast Imaging
American College of Radiology (ACR) Launches Contrast-Enhanced Mammography Imaging Screening Trial (CMIST) in Collaboration With GE Healthcare and the Breast Cancer Research Foundation

October 19, 2022 — The American College of Radiology (ACR) is set to launch the Contrast-Enhanced Mammography Imaging ...

Time October 19, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now